From the side effects of SGLT2 inhibitors discussed above, urinary tract infections seem to be the most concerning problem for clinicians, which limits the administration of this class of drugs despite their multiple demonstrated benefits. This evidence concerns the gene SLC5A2 and urinary tract infection.